Management of Long COVID—The CoviMouv' Pilot Study: Importance of Adapted Physical Activity for Prolonged Symptoms Following SARS-CoV2 Infection
Claire Colas(Inserm), David Hupin(Université Claude Bernard Lyon 1), Léonard Féasson(Université Claude Bernard Lyon 1), Pierre Labeix(Inserm), E. Breugnon(Centre Hospitalier Universitaire de Saint-Étienne), Frédéric Roche(Université Claude Bernard Lyon 1), Manon Bayle(Centre Hospitalier Universitaire de Saint-Étienne), Arnauld Garcin(Inserm), F. Schein(Centre Hospitalier Universitaire de Saint-Étienne), Amandine Gagneux‐Brunon(Université Claude Bernard Lyon 1), Céline Cazorla(Centre Hospitalier Universitaire de Saint-Étienne), Élisabeth Botelho-Nevers
Cited by 39
Related Papers
Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged ≥60 years: a systematic review and meta-analysis
|British Journal of Sports Medicine|2015|566
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Physical Activity in Long COVID: A Comparative Study of Exercise Rehabilitation Benefits in Patients with Long COVID, Coronary Artery Disease and Fibromyalgia
|International Journal of Environmental Research and Public Health|2023|35
Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown
|Frontiers in Psychology|2021|29